The Future of Organ-on-a-Chip
Dozens of solutions have been suggested to lessen the crisis that has been hitting pharma R&D recently. Over the last decade, the cost of creating drugs has skyrocketed even as the amount of new medicines reaching market is steadily declining....
5 years agoThe Future of Organ-on-a-Chip
Dozens of solutions have been suggested to lessen the crisis that has been hitting pharma R&D recently. Over the last decade, the cost of creating drugs has skyrocketed even as the amount of new medicines reaching market is steadily declining....
5 years ago
Proventa’s Weekly Round-up – 20/12/19
Merry Christmas! This week in our segment on “the same three stories every week that are of broad general interest”, Trump’s administration has made an attempt to reduce U.S. drug prices with a plan to allow Canadian imports; Nancy Pelosi’s...
5 years agoProventa’s Weekly Round-up – 20/12/19
Merry Christmas! This week in our segment on “the same three stories every week that are of broad general interest”, Trump’s administration has made an attempt to reduce U.S. drug prices with a plan to allow Canadian imports; Nancy Pelosi’s...
5 years ago
Proventa’s Weekly Round-up – 13/12/19
Avoiding yesterday’s election and all it means for the UK and Brexit, much of the news this week happened across the pond: Pharma companies have reacted violently to the Republicans’ alleged reneging of drug patent rules in international negotiations, while...
5 years agoProventa’s Weekly Round-up – 13/12/19
Avoiding yesterday’s election and all it means for the UK and Brexit, much of the news this week happened across the pond: Pharma companies have reacted violently to the Republicans’ alleged reneging of drug patent rules in international negotiations, while...
5 years ago
AI and Pharmacovigilance ADR processing
Many of the problems that have long been inherent in Pharmacovigilance (PV) - such as historic limitations in the information that is published in case reports, analysis of electronic health records and integration - have found an answer in the...
5 years agoAI and Pharmacovigilance ADR processing
Many of the problems that have long been inherent in Pharmacovigilance (PV) - such as historic limitations in the information that is published in case reports, analysis of electronic health records and integration - have found an answer in the...
5 years ago
Time to invest in CGT: Its Benefits for Pharma
The concept of cell and gene therapy (CGT), wherein scientists and healthcare experts adapt cells and genes to treat illnesses, is nothing new in the life science space. Even the relatively new CRISPR has transformed into a household buzzword over...
5 years agoTime to invest in CGT: Its Benefits for Pharma
The concept of cell and gene therapy (CGT), wherein scientists and healthcare experts adapt cells and genes to treat illnesses, is nothing new in the life science space. Even the relatively new CRISPR has transformed into a household buzzword over...
5 years ago
Single-Use Technologies: Challenges and Solutions
Since their increased popularisation from the mid-1990s, single- and limited-use technologies (collectively SUTs) have changed the field of biomanufacturing. This has been driven partly by the heavy growth of the pharma market, from $162 billion in 2014 to around $270...
5 years agoSingle-Use Technologies: Challenges and Solutions
Since their increased popularisation from the mid-1990s, single- and limited-use technologies (collectively SUTs) have changed the field of biomanufacturing. This has been driven partly by the heavy growth of the pharma market, from $162 billion in 2014 to around $270...
5 years agoInterested?
Reserve your space
